1.
Khemla S, Meesing A, Sribenjalux W, Chetchotisakd P. Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir. dti [Internet]. 2023 Apr. 28 [cited 2024 Apr. 24];17(1):45-53. Available from: https://journals.aboutscience.eu/index.php/dti/article/view/2529